{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieozptso6nqhbvd5bijfbliih7ozorpqaz53wtwnhxrjnkm5r7dxa",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3modyoriocud2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiakgwoxshs2cbykf7v2vooof7oyisai3635dt35xl353nbgxuvkpy"
    },
    "mimeType": "image/jpeg",
    "size": 139056
  },
  "path": "/news/2026-06-immunotherapy-tumor-triggered-neutrophils-cancer.html",
  "publishedAt": "2026-06-15T13:40:10.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Certain white blood cells in the immune system, known as neutrophils, can make cancer immunotherapy less effective, according to a new study from Karolinska Institutet published in the journal Immunity. The results show that a signaling molecule in the tumor affects neutrophils, reducing the effect of treatment.",
  "title": "Why some immunotherapy fails: Tumor-triggered neutrophils can shut down cancer-killing T cells"
}